Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief | The Appointment of Dr Matthew Hepburn to Expand Panther’s Leadership For Next Generation Immune-Mediated Therapies

In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.